##Prevention of Brain Atrophy in MS Clinical Trials and Possible Role in Clinical Practice
Thursday, September 7, 2017 at 10:00 am
de Grandpré Communications Centre, Montreal Neurological Institute
###Anthony Traboulsee, MD, FRCPC
Dr. Anthony Traboulsee is an Associate Professor (Neurology) and Research Chair of the MS Society of Canada at the University of British Columbia in Vancouver, Canada. He is the Director of the MS/NMO Clinic and Clinical Trials Research Group at UBC Hospital. His research focus is on clinical trial design, the development of practice guidelines for the use of MRI in the management of MS, establishing advanced MRI imaging outcomes in Multiple Sclerosis, and the treatment of Neuromyelitis Optica.
Objectives:
- Discuss mechanisms of brain atrophy in MS
- Review impact of treatments on brain atrophy and pseudoatrophy
- Role of clinical MRI in monitoring brain atrophy in routine patient care